Global Blood Glucose Monitoring Market Size, Trends and Growth Analysis By Product Type (Invasive, Continuous, Flash), Application (Type 1 Diabetes, Type 2 Diabetes) and End User (Diagnostic Centers, Hospitals, Clinics) - Forecast till 2027
Blood glucose monitoring can be referred to as the procedure of testing diabetes level in the blood. It assists in identifying the glucose level of blood within a specific target range. These monitoring devices offer useful insights in order to manage diabetes. The global blood glucose monitoring market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 7.1% during the forecast period (2017-2023).
The blood glucose monitoring market is considered one of the rapidly expanding markets, mainly due to the surging growth in urbanization, leading to soaring incidences of obesity. Physical inactiveness and unhealthy diet among the population has further resulted in increased diabetic population across the globe, thereby augmenting the market growth. Developments in technology, increased investment in R&D activities, and surging awareness regarding these devices are some of the primary growth stimulants of the market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/557
On the contrary, the high cost of blood glucose monitoring devices will restrict its growth in the foreseeable future. Moreover, the lack of reimbursement policies for such devices will remain a major barrier to the adoption of such devices.
Global Blood Glucose Monitoring Market: Segmental Analysis
The global blood glucose monitoring market has been segmented on the basis of application, product type, and end user.
By product type, the blood glucose monitoring market is segmented into continuous glucose monitoring devices (CGM), invasive glucose monitoring devices, flash glucose monitoring devices, and others. Of these, the CGM segment will register significant growth, owing to the surging adoption of minimally invasive procedures.
By application, the market is segmented into type 1 diabetes, type 2 diabetes, and others. Of these, type 2 diabetes will gain prominence due to rising incidences of type 2 diabetes and innovative product launches with less invasive technologies.
The end users segment comprises hospitals, diagnostic centers, research centers, clinics, and home care diagnostics. Of these, the home care diagnostics is predicted to gain prominence due to the surge in diabetic population, along with surging awareness regarding regular monitoring of glucose levels. Also, rising product launches enhance patient comfort when used at home.
Geographically, the blood glucose monitoring market spans across Europe, Asia Pacific, America, and the Middle East & Africa.
Considering the global scenario, America commands the largest share in the global market, mainly due to the surging incidences of obesity among the global population. Physical inactivity and unhealthy diet of the consumers are estimated to encourage the market growth in the region. As per the CDC, the prevalence of diagnosed as well as undiagnosed diabetes population in 2015 was around 30.3 million people of all ages. The market is predicted to experience a surge due to the presence of well-developed technology, rising R&D activities, increased spending on healthcare, and high concentration of major players in the region.
Europe acquires the second spot in the blood glucose monitoring market due to environmental pollutants, socioeconomic deprivation, and psychological factors. Government support for R&D, along with the high availability of funds for research will further enhance the regional market’s growth in the coming years.
Meanwhile, the Asia Pacific will expand at the fastest rate due to ever-increasing geriatric population, changing lifestyle, and rapid urbanization in the region. The rising incidences of rapidly developing healthcare technology, R&D activities, increased expenditure on healthcare, and concentration of industry bigshots have propelled the market growth in the APAC. Soaring demand for new treatment methods, especially in economies like South Kore and India will augment the market growth.
The top players operating in the blood glucose monitoring market include Arkay, Inc. (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bayer Healthcare AG (Germany), GlySure Ltd (U.K), Goldsite Diagnostics Inc., Dexcom, Inc. (U.S.), Sphere Medical Holding plc. (U.K), and LifeScan, Inc. (U.S.).
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/blood-glucose-monitoring-market-557
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312
Email: [email protected]